Clinic Flashcards
Gonorrhea and Chlamydia screening
Annual for sexually actively ages 13-24
Diabetes screening
Annually if high risk
Every 3 years after age 45
HbA1c
- 6.5% diabetes
- 5.7-6.4% pre-diabetes
Cholesterol screening
Every 5 years beginning at age 40
Screening post hysterectomy for high-grade cytology or histology (CIN 2/3, AIS)
Annual screening for 3 years > every 3 years for 25 years
Regression rates of CIN 1 and 2
CIN 1: 60%
CIN 2: 40%
Negative predictive value of co-testing
99% for CIN 2/3
- pap 50% sensitive
- liquid cytology 76% sensitive
When is an ECC indicated during colposcopy?
No identifiable lesion
Unsatisfactory colposcopy
Pap with ASC-H, HSIL, AGC, or AIS
When considering ablative therapy for CIN 1/2
Treatment for positive margin on CIN 2/3 excision
Cotesting or colposcopy with ECC in 6 months > annual cotesting for 3 years
Screening options for colon cancer
Yearly fecal blood cards Sigmoidoscopy every 5 years CT colonography every 10 years Colonoscopy every 10 years - start at 45 or 10 years before first degree family member
Follow up for abnormal colonoscopy
Benign polyps: 3-5 years
Atypical polyp: 3 years
Breast screening in BRCA 1/2 patients
Annual MRI starting at age 25
Annual mammography at age 30
- Consider tamoxifen and risk-reducing surgery
- 45-85% risk of breast cancer
High risk cholesterol
Total cholesterol > 240
LDL > 160
HDL < 40
Triglycerides > 885
Lifestyle changes and then statin
T-score
Standard deviation from mean peak bone density of normal young adult
Z-score
Standard deviation from reference population of same age, sex, and race
Lab work up for osteoporosis
CBC
CMP
Vitamin D level
Consider 24 hour urinary calcium, PTH, TSH
FRAX score
Estimates 10-year probability of hip fracture or major fracture for untreated patients using femoral neck bone mineral density and risk factors
Candidates for osteoporosis treatment
Osteoporosis
Postmenopausal
- osteopenia with hip fracture 3% or major fracture >20% by FRAX
Calcium requirements daily
Age 9-18: 1300 mg calcium
Age 19-50: 1000 mg calcium
Age 50+: 1200 mg calcium
Vitamin D requirement daily
1-70 years: 600 IU/day
70+ years: 800 IU/day
Risk reduction for fracture
No free rugs
Slip on shoes
Store objects at eye level
Optimize vision
Mechanism of bisphosphonates (Fosamax, Boniva, Reclast)
Inhibits bone resorption by osteoclasts
Same ultimate pathway as calcitonin
Mechanism of calcitonin
Binds to osteoclasts and inhibits bone resorption
Exercise recommendation for reducing heart disease
30 minutes 5 days a week
Emergency contraceptive options
Up to 3 days - Levonorgestrel 1.5 mg once Up to 5 days - Ulipristal 30 mg once - Copper IUD
UTI treatment
Tmp-smx 100/800 bid x 3 days
Nitrofuratoin 100 mg bid x 7 days
Fosfomycin 3 mg once
Criteria for inpatient PID treatment
Surgical emergency not excluded Pregnancy No response to oral therapy Peritonitis, n/v, high fever Noncompliance with treatment
Amstels criteria for bacterial vaginosis
3 of 4:
- pH > 4.5
- positive KOH whiff test (10% KOH)
- > 20% clue cells on saline microscopy
- Homogenous, thin, white-gray discharge coating vaginal walls
Most common cause of congenital adrenal hyperplasia
21-hydroxylase deficiency
- measure with 17-ohp (elevated)
- consider testing in secondary amenorrhea
Order of puberty
Growth spurt Breast development Pubarche Adrenarche Menarche
Lab work up of hitsuitism
Total testosterone
DHEAS
17-OH progesterone
Reassuring endometrial stripe in post menopausal patient
4 mm or less
Treatment for recurrent bacterial vaginitis (3+ episodes in a year)
Twice weekly suppressive metronidazole gel for 16 weeks
After treatment of acute episode
Diagnosis of trichomonas
NAAT of vaginal, cervical, or urine specimens
- Microscopy only 50% sensitive
Treatment of trichomoniasis
Metronidazole 500 mg BID for 7 days
Tinidazole 2 gram in a single dose
Treatment of bacterial vaginosis
Metronidazole 500 mg BID for 7 days Metronidazole gel 0.75% daily for 5 days Clindamycin cream 2% daily for 7 days Tinidazole 2 mg daily for 2 days Secnidazole 2 g orally once
Treatment of trichomoniasis with metronidazole allergy
Metronidazole desensitization
Treatment of uncomplicated vulvovaginal candidiasis
Fluconazole 150 mg once
Miconazole 4% for 3 days
Clotrimazole 2% for 3 days
Treatment of recurrent vulvovaginal candidiasis
Weekly fluconazole 150 mg for 6 months
After Fluconazole 150mg q72hrs for 3 doses
Treatment of severe vulvovaginal candidiasis
Topical intravaginal azole for 10-14 days
Fluconazole 150 mg every 72 hours for 2-3 doses
Treatment of C glabrata
Intravaginal boric acid (600 mg capsules) daily for 14 days
High potency topical corticosteroids
Triamcinolone 0.5%
Bethamethasone, clobetasol, halobetosol, fluocinonide 0.05%
Low potency corticosteroids
Hydrocortisone 1%, 2.5%
Desonide 0.05%
Component of lichen planus evaluation
Oral exam and referral to periodontist as needed
Labs for AUB
CBC, tsh, hCG, cervical cancer screening, chlamydia testing
- consider prolactin
PALM structural causes for AUB
Polyp
Adenomyosis
Leiomyoma
Malignancy and hyperplasia
COEIN for non-structural causes of AUB
Coagulopathy Ovulatory dysfunction Endometrial Iatrogenic Not yet classified
Main Hpv strains causing condyloma
6 and 11
Complications of DES exposure
Vaginal adenosis (persistence of columnar epithelium in upper 1/3 of vagina, normally replaced by squamous) > clear cell adenocarcinoma
Müllerian duct derivative not replaced by Urogenital sinus derivatives